Elanco Animal Health Inc [ELAN] stock is trading at $15.07, up 2.87%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ELAN shares have gain 4.73% over the last week, with a monthly amount glided 2.66%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on September 19, 2024, when Morgan Stanley downgraded its rating to a Equal-Weight and also revised its price target to $15 from $17. Previously, Stifel upgraded its rating to Buy on January 05, 2024, and elevated its price target to $20. On December 19, 2023, Jefferies initiated with a Buy rating and assigned a price target of $17 on the stock. Morgan Stanley upgraded its rating to a Overweight but stick to its price target of $16 on December 15, 2023. Exane BNP Paribas initiated its recommendation with a Outperform and recommended $18 as its price target on December 07, 2023. Barclays upgraded its rating to Overweight for this stock on April 20, 2023, but kept the price target unchanged to $14. In a note dated August 18, 2022, Morgan Stanley downgraded an Equal-Weight rating on this stock and revised its target price from $37 to $22.
Elanco Animal Health Inc [ELAN] stock has fluctuated between $8.52 and $18.80 over the past year. Currently, Wall Street analysts expect the stock to reach $25.83 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $15.07 at the most recent close of the market. An investor can expect a potential return of 71.4% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
Elanco Animal Health Inc [NYSE:ELAN] reported sales of 4.49B for the trailing twelve months, which represents a growth of 12.02%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.21 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.96.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.96 points at the first support level, and at 12.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.98, and for the 2nd resistance point, it is at 16.89.
Ratios To Look Out For
For context, Elanco Animal Health Inc’s Current Ratio is 2.93. In addition, the Quick Ratio stands at 1.75 and the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 1.66, the price to book ratio is 1.25.
Transactions by insiders
Recent insider trading involved Harrington Michael J, Director, that happened on Aug 22 ’24 when 3500.0 shares were purchased. PRESIDENT, CEO AND DIRECTOR, Simmons Jeffrey N completed a deal on Aug 12 ’24 to buy 100000.0 shares. Meanwhile, Director DOYLE WILLIAM F bought 15000.0 shares on May 21 ’24.
